Atlas Trials

Targeted Imaging of Glutamate Carboxypeptidase II With DCFPyL-PET

Clinical trial NCT03542773 · COMPLETED

Trial details

NCT number
NCT03542773
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
SchwannomasMalignant Tumors
Start date
2015-02-06
Primary completion
2022-05-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.